Home » Stocks » Conformis

Conformis, Inc. (CFMS)

Stock Price: $0.741 USD -0.015 (-1.98%)

Updated Oct 23, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap	57.47M
Revenue (ttm)	73.14M
Net Income (ttm)	-25.62M
Shares Out	77.56M
EPS (ttm)	-0.39
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Dividend Yield	n/a

Stock Quote

Trading Day	Oct 23, 2020
Last Price	$0.741
Previous Close	$0.756
Change ($)	-0.015
Change (%)	-1.98%
Day's Open	0.759
Day's Range	0.740 - 0.768
Day's Volume	211,383
52-Week Range	0.500 - 2.390

More Stats

Market Cap	57.47M
Enterprise Value	69.42M
Earnings Date (est)	Nov 4, 2020
Ex-Dividend Date	n/a
Shares Outstanding	77.56M
Float	69.92M
EPS (basic)	-0.38
EPS (diluted)	-0.39
FCF / Share	-0.17

Dividend	n/a
Dividend Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a
Payout Ratio	n/a
Shares Short	577,497
Short Ratio	1.16
Short % of Float	0.83%
Beta	1.80

PE Ratio	n/a
Forward PE	n/a
P/FCF Ratio	n/a
PS Ratio	0.79
PB Ratio	6.81
Revenue	73.14M
Operating Income	-23.02M
Net Income	-25.62M
Free Cash Flow	-11.38M

Net Cash	-11.96M
Net Cash / Share	-0.15
Gross Margin	50.23%
Operating Margin	-31.47%
Profit Margin	-35.00%
FCF Margin	-15.56%
ROA	-21.43%
ROE	-143.36%
ROIC	-44.90%

Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (4)

Buy	3
Overweight	0
Hold	0
Underweight	0
Sell	1

What these ratings mean

Analyst Consensus: Overweight

Price Target

$2.33*

(214.44% upside)

Low

2.00

Current: $0.741

High

3.00

Target: 2.33

*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year	2019	2018	2017	2016	2015	2014	2013
Revenue	77.43	89.79	78.12	79.90	66.89	48.19	34.60
Revenue Growth	-13.77%	14.94%	-2.23%	19.45%	38.81%	39.28%	-
Gross Profit	36.74	48.49	28.81	26.71	21.79	15.81	7.31
Operating Income	-25.13	-38.69	-55.85	-56.14	-55.96	-45.43	-47.31
Net Income	-28.48	-43.37	-53.58	-57.59	-57.25	-45.72	-47.89
Shares Outstanding	64.12	58.89	43.34	41.52	21.99	4.24	4.00
Earnings Per Share	-0.44	-0.74	-1.24	-1.39	-2.60	-10.78	-11.98
Operating Cash Flow	-2.84	-25.18	-37.86	-49.13	-54.45	-43.54	-46.83
Capital Expenditures	-2.93	-4.06	-5.23	-7.16	-4.64	-2.61	-4.11
Free Cash Flow	-5.76	-29.24	-43.09	-56.29	-59.09	-46.15	-50.94
Cash & Equivalents	26.86	24.09	45.69	65.80	118	42.34	59.77
Total Debt	26.16	14.79	29.67	-	0.48	10.62	3.11
Net Cash / Debt	0.69	9.30	16.02	65.80	117	31.72	56.66
Assets	72.40	62.98	93.80	113	159	71.28	83.89
Liabilities	56.05	26.78	47.29	18.76	18.16	21.45	14.93
Book Value	16.35	36.20	46.51	94.06	141	49.83	68.96

Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name	Conformis, Inc.
Country	United States
Employees	262
CEO	Mark A. Augusti

Stock Information

Ticker Symbol	CFMS
Stock Exchange	NASDAQ
Sector	Healthcare
Industry	Medical Devices
Unique Identifier	NASDAQ: CFMS
IPO Date	July 1, 2015

Description

Conformis, a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers personalized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a personalized bicompartmental knee replacement system; and iUni, a personalized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides Conformis Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation. The company markets and sells its products to hospitals and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, Hong Kong, Malaysia, Monaco, Hungary, Spain, and Australia. Conformis, Inc. was founded in 2004 and is headquartered in Billerica, Massachusetts.